University of Central Florida Music Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorUniversity of Central Florida
About this trial
The purpose of this study is to scientifically validate the impact of music therapy on Alzheimer's disease (AD) by analyzing molecular biomarkers in salivary exosomes. Exosomes are extracellular vesicles that carry molecular signals from brain cells, providing a non-invasive method to assess physiological changes.
Eligibility criteria
Qualifiers
50 years old or older.
20 adults with no mild-cognitive impairment
20 adults with mild-cognitive impairment
20 adults with Alzheimer's disease/ dementia.
Disqualifiers
49 years and younger
prisoners
unable to understand English and provide consent
Trial design
Treatments tested in this trial
- Music intervention
Treatment groups
60 Participants
are divided into 1 treatment groupLocations
1University of Central Florida32827, OrlandoFlorida, United States
Sponsors and collaborators
University of Central Florida
Lead sponsor
Source ClinicalTrials.gov